Biologic-to-Biosimilar Switches Deemed Safe and Effective Biologic-to-Biosimilar Switches Deemed Safe and Effective

Triple switching from infliximab biologic to biosimilar for IBD found no new safety or efficacy concerns.MDedge News
Source: Medscape Gastroenterology Headlines - Category: Gastroenterology Tags: Gastroenterology News Source Type: news